Clinical and Laboratory Effects of Thyrombolytic Therapy in Acute Myocardial Infarction a Placebo Controlled Study

HASAN GÖK, Bayram Korkut, Talat Tavlı, Alaaddin Avşar

  • Yıl : 1993
  • Cilt : 9
  • Sayı : 2
  •  Sayfa : 191-193
Several studies have shown that infarct size is re-duced after trombolytic treatement in patients with acute myocardial infarction. The present study was pelformed to compare clinical and laboratory results in acute myocardial infarction patients following ei-ther intravenous thrombolysis or plasebo in our Co-ronary Care Unite. We peiformed intravenous strep-tokinase (n=46) within 6 hours from onset of chest hain. Total hospitalization days were not changed between patients with thrombolytic treatement and Placebo (10±4 gün vs 11 ±5 gün, p<0.304, respectively). CK-MB started significantly to change after 6 hours (176±138 mgldl, p<0.01). CPK, reached its peak level within 12 hours after thrombolytic treate-ment. SGOT, SGPT and LDII begun significantly change within 18 hours after thrombolytic treate-ment. Cholesterol, trigliserit, LDL were not changed significantly. But HDL increased significantly in pa-tients with thrombolytic treatement within 18 hours after thrombolytic treatment.
Atıf yapmak için :
Açıklama : Yazarların hiçbiri, bu makalede bahsedilen herhangi bir ürün, aygıt veya ilaç ile ilgili maddi çıkar ilişkisine sahip değildir. Araştırma, herhangi bir dış organizasyon tarafından desteklenmedi.Yazarlar çalışmanın birincil verilerine tam erişim izni vermek ve derginin talep ettiği takdirde verileri incelemesine izin vermeyi kabul etmektedirler.
Clinical and Laboratory Effects of Thyrombolytic Therapy in Acute Myocardial Infarction a Placebo Controlled Study
, Vol. 9 (2)
Geliş Tarihi : 22.10.1993, Kabul Tarihi : 22.10.1993, Yayın Tarihi : 22.10.2020
Selçuk Tıp Dergisi
ISSN:1017-6616;
E-ISSN:2149-8059;